John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
Antibiotic Prescribing Practices During COVID-19
November 21st 2021As providers were challenged to care for patients with severe COVID-19 In the first year of the pandemic, antibiotic usage increased. Listen to clinicians talk about this specific challenge and how prescribing practices evolved over time.
Read More
Antibiotics: From Accidental Discovery to Cornerstone of Medicine
November 19th 2021From its origins as a serendipitous discovery to being successfully prescribed for nearly a century, antibiotics remain a foundation of medicine. However it has major ongoing challenges including the rise of superbugs and the development of antimicrobial resistance (AMR). There are some prospective strategies to combat AMR on the horizon.
Read More
Pfizer Signs Agreement for its COVID-19 Oral Antiviral Treatment for Low and Middle Income Countries
November 16th 2021This agreement with the Medicines Patient Pool (MPP) would allow licensing of the company’s antiviral treatment candidate, PF-07321332, internationally to numerous countries.
Read More
Investigational Therapies, Modalities May Change Recurrent C Difficile Treatment Trajectory
November 11th 2021During the C Diff Foundation's Annual conference, providers and stakeholders offered insights on the latest investigational therapies and modalities as they advance through clinical trials.
Read More
Moving Forward: Investigational C Diff Vaccine, Therapeutics Headline Conference
November 4th 2021Highlights from the morning session of the C Diff Foundation Conference included data about Pfizer's investigational vaccine, insights about Seres Therapeutics microbiome therapeutic, and a look at CDI incidence rates around COVID-19.
Read More
The Role of Antimicrobial Stewardship in Deterring C Difficile
November 4th 2021The development of these programs are being looked at for private practices in the community settings to try to create better prescribing practices and avoid the potential progression to health care associated infections.
Read More